الملكية العامة. Min T، Bain SC (يناير 2021). "The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS
Bao F، Yu L، Babu S، Wang T، Hoffenberg EJ، Rewers M، Eisenbarth GS (1999). "One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac
combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives. For use only for the treatment
Sarngadharan MG، Robert-Guroff M، Miyoshi I، Golde D، Gallo RC (نوفمبر 1982). "A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell